Search Results 31-40 of 18640 for Hepatitis b
Low hepatitis B surface antigen antibody titers in fully vaccinated patients may not indicate a lack of immunity.
Hepatitis A is a contagious liver infection caused by a virus. Learn how the disease spreads and what you can do to prevent or treat it.
This disease happens most often in people with liver scarring, called cirrhosis, caused by hepatitis B or hepatitis C infection. In these people, the cancer ...
Adefovir is used to treat chronic (long-term) hepatitis B virus (HBV) infection in patients who are at least 12 years of age. Adefovir is not a cure for the ...
The immune response to gluten in these patients may interfere with developing immunity from vaccination for hepatitis B, according to some research, but not all ...
Immunity to Hepatitis B through vaccination in patients with inflammatory bowel disease and chronic liver disease is crucial due to high risk of morbidity.
Lamivudine is also used to treat chronic (long-term) hepatitis B virus (HBV) infection. This medicine is available only with your doctor's prescription ...
Most people with this type of cancer have an ongoing liver condition, such as cirrhosis caused by hepatitis B or hepatitis C infection. Hepatocellular carcinoma ...
Study suggests that screening fully vaccinated inflammatory bowel disease (IBD) patients for hepatitis B immunity is not needed.
Description. Entecavir is used to treat liver infection caused by hepatitis B virus. It belongs to the family of medicines called antivirals.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.